- Home
- MRBK vs RPTX Comparison
MRBK vs RPTX Comparison
Compare MRBK & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRBK | RPTX |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 92.4M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MRBK | RPTX |
|---|---|---|
| Price | $18.08 | $2.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $18.00 | $3.00 |
| AVG Volume (30 Days) | 81.4K | ★ 1.5M |
| Earning Date | 01-23-2026 | 03-02-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ 75.95 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | ★ $109,758,000.00 | $11,870,000.00 |
| Revenue This Year | $26.48 | N/A |
| Revenue Next Year | $7.79 | $2,122.22 |
| P/E Ratio | $10.27 | ★ N/A |
| Revenue Growth | ★ 18.84 | N/A |
| 52 Week Low | $11.16 | $0.89 |
| 52 Week High | $18.33 | $2.66 |
Technical Indicators
Market Signals| Indicator | MRBK | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.01 | 65.60 |
| Support Level | $17.05 | $2.52 |
| Resistance Level | $18.28 | $2.61 |
| Average True Range (ATR) | 0.45 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 77.96 | 29.63 |
Price Performance
Historical ComparisonAbout MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.